1. Spontaneous Hemorrhage Associated With Synthetic Cannabinoid Use
- Author
-
Jennifer McMahon, Adrienne Markiewicz, Pamela Souders, Ann M. Parks, and Sarah Peppard
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,Recreational Drug ,business.industry ,Nurse practitioners ,medicine.medical_treatment ,Public health ,030204 cardiovascular system & hematology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,chemistry ,Synthetic cannabinoids ,Medicine ,Spontaneous hemorrhage ,030212 general & internal medicine ,Cannabinoid ,business ,Intensive care medicine ,Brodifacoum ,Superwarfarin ,medicine.drug - Abstract
Synthetic cannabinoids (SCBs) are a popular new class of designer drugs. In 2018, the Centers for Disease Control and Prevention advised that illicit products containing SCB compounds were laced with brodifacoum (BDF), a highly potent superwarfarin easily purchased as a rodenticide. Multiple outbreaks of bleeding from BDF exposure have since been reported. Patients with BDF toxicity present with bleeding ranging from mild epistaxis to life-threatening hemorrhage. Given the increasing popularity of SCBs as recreational drugs, outbreaks from BDF exposure are likely to continue, presenting a public health risk. The nurse practitioner has a vital role in the complex, ongoing management of this patient population.
- Published
- 2019
- Full Text
- View/download PDF